Bruker Corporation (BRKR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bruker Corporation (BRKR) has a cash flow conversion efficiency ratio of 0.092x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($229.80 Million) by net assets ($2.51 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bruker Corporation (BRKR) total market value for the company's overall valuation and market capitalisation.
Bruker Corporation - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Bruker Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bruker Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bruker Corporation ranked by their cash flow conversion efficiency. Explore BRKR operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Sunlord Electronics Co Ltd
SHE:002138
|
0.052x |
|
Shan Dong Sun Paper Industry Joint Stock Co Ltd
SHE:002078
|
0.046x |
|
WPG Holdings Ltd
TW:3702
|
-0.598x |
|
Bank of Changsha Co Ltd
SHG:601577
|
1.054x |
|
SDIC Essence Holdings Co Ltd
SHG:600061
|
0.156x |
|
CAVA Group, Inc.
NYSE:CAVA
|
0.052x |
|
Grinm Advanced Materials Co Ltd
SHG:600206
|
-0.092x |
|
Migdal Insurance
TA:MGDL
|
0.382x |
Annual Cash Flow Conversion Efficiency for Bruker Corporation (1999–2025)
The table below shows the annual cash flow conversion efficiency of Bruker Corporation from 1999 to 2025. View Bruker Corporation stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.51 Billion | $134.10 Million | 0.053x | -61.41% |
| 2024-12-31 | $1.82 Billion | $251.30 Million | 0.138x | -44.11% |
| 2023-12-31 | $1.41 Billion | $350.10 Million | 0.248x | +7.01% |
| 2022-12-31 | $1.13 Billion | $262.00 Million | 0.231x | -11.08% |
| 2021-12-31 | $1.08 Billion | $282.40 Million | 0.260x | -23.88% |
| 2020-12-31 | $974.30 Million | $333.20 Million | 0.342x | +50.35% |
| 2019-12-31 | $938.20 Million | $213.40 Million | 0.227x | -14.11% |
| 2018-12-31 | $905.10 Million | $239.70 Million | 0.265x | +25.81% |
| 2017-12-31 | $733.50 Million | $154.40 Million | 0.210x | +11.54% |
| 2016-12-31 | $693.10 Million | $130.80 Million | 0.189x | -39.65% |
| 2015-12-31 | $732.90 Million | $229.20 Million | 0.313x | +111.14% |
| 2014-12-31 | $771.70 Million | $114.30 Million | 0.148x | -13.15% |
| 2013-12-31 | $850.20 Million | $145.00 Million | 0.171x | -9.08% |
| 2012-12-31 | $709.60 Million | $133.10 Million | 0.188x | +33.65% |
| 2011-12-31 | $624.90 Million | $87.70 Million | 0.140x | -52.58% |
| 2010-12-31 | $527.40 Million | $156.10 Million | 0.296x | -17.25% |
| 2009-12-31 | $418.80 Million | $149.80 Million | 0.358x | +4.63% |
| 2008-12-31 | $312.70 Million | $106.90 Million | 0.342x | +214.12% |
| 2007-12-31 | $259.20 Million | $28.21 Million | 0.109x | -44.65% |
| 2006-12-31 | $191.71 Million | $37.69 Million | 0.197x | -3.06% |
| 2005-12-31 | $208.03 Million | $42.19 Million | 0.203x | +5061.32% |
| 2004-12-31 | $217.47 Million | $-889.00K | -0.004x | +86.39% |
| 2003-12-31 | $202.55 Million | $-6.08 Million | -0.030x | +66.67% |
| 2002-12-31 | $126.38 Million | $-11.39 Million | -0.090x | -0.18% |
| 2001-12-31 | $127.55 Million | $-11.47 Million | -0.090x | -5430.38% |
| 2000-12-31 | $124.17 Million | $-202.00K | -0.002x | -100.30% |
| 1999-12-31 | $10.06 Million | $5.44 Million | 0.541x | -- |
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, ser… Read more